Table 6.
Multivariate logistic regression analysis of established and experimental factors for predicting a clinical response after two cycles, irrespective of study treatment
| Odds ratio | 95% CI | p Value | |
| Menopausal status | 1.35 | 0.72 to 2.55 | 0.351 |
| Tumour size | 0.93 | 0.49 to 1.75 | 0.821 |
| Clinical nodal status | 1.04 | 0.56 to 1.94 | 0.903 |
| Grade | 0.67 | 0.33 to 1.38 | 0.279 |
| ER | 1.09 | 0.43 to 2.77 | 0.850 |
| PgR | 0.56 | 0.23 to 1.35 | 0.195 |
| Ki-67 | 0.58 | 0.29 to 1.15 | 0.120 |
| HER2 | 0.99 | 0.46 to 2.16 | 0.990 |
| p53 | 1.43 | 0.69 to 2.96 | 0.338 |
| bcl-2 | 2.75 | 1.27 to 5.97 | 0.011 |
ER, oestrogen receptor; HER2, human epidermal growth factor receptor 2; PgR, progesterone receptor.